Plain-English translation of NCT06190613 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a support program called iCARE Nigeria designed to help young people with HIV stay engaged in their treatment. The program combines two things: a peer navigator (someone with lived HIV experience who provides one-on-one support) and text message reminders to help you remember to take your HIV medications. The study wants to see if this combination approach helps people stick with their treatment plan and achieve viral suppression—meaning the amount of virus in their blood drops to undetectable levels.
Young sexual and gender minority people with HIV in Nigeria often struggle to stay consistently on treatment, which can lead to the virus becoming harder to control. This study exists to see if adding personalized peer support and simple text message reminders can help more young people take their medications as prescribed and reach viral suppression, which is critical for their health and prevents transmission to others.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the new peer support and text message reminder program or to continue with standard care at your clinic. The entire study lasts 24 weeks (about 6 months). If you're in the intervention group, you'll meet regularly with a peer navigator who understands your experience and can help you stay on track with your treatment, and you'll receive text message reminders about taking your HIV medications. Throughout the study, the researchers will check your viral load through blood tests and look at your medication adherence and how often you attend clinic visits.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Nigeria
Sponsor
Northwestern University
Collaborators
National Institute of Mental Health (NIMH)
Enrollment target
~100 participants
Started
November 2024
Primary completion
August 2026
Age range
15 Years – 29 Years
Sex
Male only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lisa Kuhns, PhD
Northwestern University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.